Yogesh Aher

Yogesh Aher, PhD, possesses extensive experience in pharmaceutical chemistry and biological sciences, with a notable history of research and development roles. At the University of Vienna, significant contributions included the discovery of anticancer compounds using hybrid virtual screening and the development of novel classification methods for P-glycoprotein substrates. Further experience as a postdoctoral researcher at the University of Cambridge involved establishing a rodent model for Multiple Sclerosis and investigating neurodevelopmental factors. At the Medical University of Vienna, Yogesh Aher executed preclinical studies for CNS drug candidates, resulting in multiple patents and publications. Subsequent roles at Enveda Biosciences and AstraZeneca included leadership in biology and in vivo target validation. Aher also holds expertise in GLP quality assurance from a prior position at PRADO Preclinical Research and Development Organisation. Education credentials include a PhD in Pharmaceutical Chemistry from the University of Vienna.